DE69833651D1 - Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut - Google Patents

Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut

Info

Publication number
DE69833651D1
DE69833651D1 DE69833651T DE69833651T DE69833651D1 DE 69833651 D1 DE69833651 D1 DE 69833651D1 DE 69833651 T DE69833651 T DE 69833651T DE 69833651 T DE69833651 T DE 69833651T DE 69833651 D1 DE69833651 D1 DE 69833651D1
Authority
DE
Germany
Prior art keywords
tretinoin
skin
vehicle
weight percent
treated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69833651T
Other languages
English (en)
Other versions
DE69833651T2 (de
Inventor
Douglas E Kligman
Albert M Kligman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69833651D1 publication Critical patent/DE69833651D1/de
Application granted granted Critical
Publication of DE69833651T2 publication Critical patent/DE69833651T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69833651T 1997-05-09 1998-05-11 Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut Expired - Fee Related DE69833651T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4607097P 1997-05-09 1997-05-09
US46070P 1997-05-09
US09/071,017 US6008254A (en) 1997-05-09 1998-05-01 Method of treating skin disorders with high-strength tretinoin
US71017 1998-05-01
PCT/US1998/009440 WO1998050023A1 (en) 1997-05-09 1998-05-11 Use of high dose retinoids for the treatment of skin disorders

Publications (2)

Publication Number Publication Date
DE69833651D1 true DE69833651D1 (de) 2006-04-27
DE69833651T2 DE69833651T2 (de) 2006-12-28

Family

ID=26723533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69833651T Expired - Fee Related DE69833651T2 (de) 1997-05-09 1998-05-11 Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut

Country Status (8)

Country Link
US (2) US6008254A (de)
EP (1) EP0980243B1 (de)
AT (1) ATE318593T1 (de)
AU (1) AU7374998A (de)
CA (1) CA2288706C (de)
DE (1) DE69833651T2 (de)
ES (1) ES2260834T3 (de)
WO (1) WO1998050023A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
MXPA02010564A (es) * 2000-04-28 2003-03-10 Hoffmann La Roche Heteroarilos y p-(sulfonil)-arilos.
US6353029B1 (en) 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
EP1385496A4 (de) 2001-05-09 2006-03-29 Univ Michigan Verwendung von zusammensetzungen zur behandlung von rosacea
WO2003057162A2 (en) * 2002-01-04 2003-07-17 Combinatorx, Incorporated Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
US20040097587A1 (en) * 2002-03-27 2004-05-20 Arbiser Jack L Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
US7390499B2 (en) 2002-04-26 2008-06-24 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds
US7704523B2 (en) * 2002-04-26 2010-04-27 Lohmann & Rauscher Gmbh Microbial cellulose wound dressing for treating chronic wounds
US20050019380A1 (en) * 2002-04-26 2005-01-27 Xylos Corporation Microbial cellulose wound dressing for treating chronic wounds
US20030203013A1 (en) * 2002-04-26 2003-10-30 Xylos Corporation Microbial cellulose wound dressing for treating chronic wounds
JP2007523156A (ja) * 2004-02-19 2007-08-16 ケマファー インコーポレイティッド 皮膚状態の処置用の局所製剤
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
SG155959A1 (en) 2004-09-28 2009-10-29 Chemaphor Inc Compositions and methods for promoting weight gain and feed conversion
KR20070089143A (ko) * 2004-12-02 2007-08-30 오엠피, 인코포레이티드 피부에 유익한 제제의 경피 흡수 향상을 위한 시스템
JP2008534514A (ja) * 2005-03-24 2008-08-28 アナコール ファーマシューティカルズ，インコーポレイテッド ボリン酸抗生物質の局所製剤およびそれらの使用法
NZ563560A (en) * 2005-06-01 2009-11-27 Stiefel Res Australia Pty Ltd Vitamin formulation for treating a dermatological skin disorder
US20060294437A1 (en) * 2005-06-22 2006-12-28 Thunder Creative Technologies, Inc. Point-of-load power conditioning for memory modules
US7709631B2 (en) 2006-03-13 2010-05-04 Xylos Corporation Oxidized microbial cellulose and use thereof
US20070286884A1 (en) * 2006-06-13 2007-12-13 Xylos Corporation Implantable microbial cellulose materials for hard tissue repair and regeneration
US20100298249A1 (en) * 2007-05-11 2010-11-25 Marc Moutet Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
AU2008316225B2 (en) * 2007-10-26 2014-06-19 Avivagen Inc. Compositions and methods for enhancing immune response
CA2975313C (en) 2009-04-30 2020-06-30 Avivagen Inc. Methods and compositions for improving the health of animals
EP3177365A4 (de) * 2014-08-06 2018-01-10 Thesan Pharmaceuticals, Inc. Agonisten des ahr-rezeptorsignalweges mit sebosuppressiver aktivität und verfahren zur identifizierung dieser agonisten
RU2018119510A (ru) * 2015-10-30 2019-12-05 Тимбер Фармасьютикалз ЭлЭлСи Композиции изотретиноина и их применение и способы

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4888342A (en) * 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
AU636595B2 (en) * 1989-01-19 1993-05-06 Ortho Pharmaceutical Corporation Method for the treatment or prevention of intrinsically aged skin with retinoids
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
AU1585692A (en) * 1991-02-27 1992-10-06 Albert M. Kligman Methods for treatment of scarring fibrotic alopecia
KR100282575B1 (ko) * 1992-02-07 2001-02-15 알버트엠.클릭만 염증성 피부병치료용 약제학적 조성물
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin

Also Published As

Publication number Publication date
US6008254A (en) 1999-12-28
EP0980243A1 (de) 2000-02-23
WO1998050023A1 (en) 1998-11-12
DE69833651T2 (de) 2006-12-28
ES2260834T3 (es) 2006-11-01
EP0980243B1 (de) 2006-03-01
CA2288706A1 (en) 1998-11-12
CA2288706C (en) 2007-10-16
ATE318593T1 (de) 2006-03-15
AU7374998A (en) 1998-11-27
US6228887B1 (en) 2001-05-08

Similar Documents

Publication Publication Date Title
DE69833651D1 (de) Verwendung hochdosierter retinoide zur behandlung von lichtgeschädigter haut
AU599135B2 (en) Methods for treatment of sundamaged human skin with retinoids
Humphreys et al. Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin
DE59410301D1 (de) Topische zubereitungen mit einem gehalt an l-arginin
BR9904650A (pt) Composição cosmética ou dermatológica tópica, processo de tratamento cosmético e utilização da composição
AU3311095A (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
ATE398995T1 (de) Hautpflegemittel die salicylsäure enthalten
EP0297733A3 (de) Catecholbutane enthaltende Arzneimittel
ATE137665T1 (de) Kosmetisches mittel
CN111437214A (zh) 一种视黄醇包裹物和抗衰祛皱精华液及其制备方法
ATE160561T1 (de) L-carnitin-salz, dieses enthaltende kosmetische und pharmazeutische zusammensetzungen zur behandlung von dermatosen
MX9806188A (es) Derivados de acidos benzofurano-acrilicos y su utilizacion como moduladores de los receptores rxrs o rars.
EP0801945A3 (de) Verwendung von Glucosiden von Ferulasäure als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
CA2065412C (en) Methods of preventing and reducing the size of striae distensae lesions
Shigematsu et al. Modulation of collagen synthesis and cell proliferation by retinoids in human skin fibroblasts
DE69717495D1 (de) Verwendung eines terminalia catappa extraktes
KR100339915B1 (ko) 셀레노아미노산의경피적용에의한외인성피부노화의재생법
BR0010121A (pt) Uso de compostos policìclicos aromáticos comoativadores dos receptores de tipo ppars eprocesso de tratamento cosmético
BR0010120A (pt) Uso de compostos policìclicos aromáticos comoativadores dos receptores de tipo ppars em umacomposição cosmética ou farmacêutica e processode tratamento cosmético
ATE271872T1 (de) Topische carbamazepin-formulierungen und deren verwendung
DE4400714A1 (de) Mittel zur Verbesserung der Wirkung extern applizierbarer kosmetischer Präparate
RU2173982C1 (ru) Крем-маска для регенерации поврежденных клеток кожи
Weber et al. Male skin care needs
Panfilov Pre-and Postoperative Skin Care
Wollina Conservative procedures in skin reconstitution

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee